Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03824093 · ClinicalTrials.gov registry record · NA

High and Low Resource Interventions to Promote HPV Vaccines

A NA study of Communication and Human Papilloma Virus, sponsored by Children's Mercy Hospital Kansas City.

Completed
Registry status
NA
Development phase
225
Enrollment target
1
Study location

NCT03824093 is a NA study of Communication and Human Papilloma Virus that has completed, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 225 participants, below the 1,414-participant average among 34 other Communication trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03824093, a NA study of Communication and Human Papilloma Virus, has completed, sponsored by Children's Mercy Hospital Kansas City.

COMPLETED
Registry status
NA
Development phase
225 participants
Enrollment target
1
Study location

Study Summary

Human Papillomavirus (HPV) is a significant public health issue affecting nearly 14 million people in the United States. HPV can lead to cervical, oropharyngeal, anal, and penile cancers as well as genital warts.The purpose of this study is to test the comparative effectiveness of two interventions, AFIX only vs. AFIX + communication training, to increase Human Papillomavirus (HPV) vaccination rates among adolescent patients in outpatient clinic settings. Providers and staff at four pediatric practices will be randomized to receive an in-person AFIX consultation or an AFIX consultation combined with communication training and commitment poster displays. Provider and parent data will be collected via a tablet computer RedCap survey. Additional practice and provider level HPV vaccination rates will be collected via patient de-identified claims data. The results of this study could contribute to the existing body of literature that suggests provider recommendations and routine vaccination assessments are key to increasing HPV vaccination uptake. This project has the potential to lead to the implementation and dissemination of low resource interventions to increase HPV vaccination rates among children and adolescents.

Interventions

  • BEHAVIORAL AFIX Only
  • BEHAVIORAL AFIX+ Provider Communication Training

Study Locations (1)

Missouri

  • Children's Mercy Hospital Kansas City - Kansas City

Trial Details

FieldValue
Enrollment Target 225 participants
Start Date 2018-07-01
Est. Completion 2020-05-06
Phase NA

What the Registry Record Tells You About NCT03824093

The ClinicalTrials.gov registry entry for NCT03824093 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 225 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,414-participant average among 34 other Communication trials with a reported enrollment target (84% lower). The listed sponsor is Children's Mercy Hospital Kansas City, which has 184 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Communication appearing as the primary indexed condition, and to 2 interventions - of which AFIX Only is the first listed.

NCT03824093 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.

Frequently Asked Questions

What is clinical trial NCT03824093 about?

NCT03824093 is a clinical study titled "High and Low Resource Interventions to Promote HPV Vaccines". Human Papillomavirus (HPV) is a significant public health issue affecting nearly 14 million people in the United States. HPV can lead to cervical, oropharyngeal, anal, and penile cancers as well as genital warts.The purpose of this study is to test the comparative effectiveness of two interventions,...

What is the current status of trial NCT03824093?

This trial is currently completed. It is a NA study. The enrollment target is 225 participants. The study started on 2018-07-01. Estimated completion is 2020-05-06.

What conditions does trial NCT03824093 study?

This clinical trial studies the following conditions: Communication, Human Papilloma Virus, Satisfaction, Meningitis, Meningococcal, Tdap - Tetanus, Diphtheria and Acellular Pertussis Vaccination.

What interventions are being tested in trial NCT03824093?

The interventions under investigation include: AFIX Only (BEHAVIORAL), AFIX+ Provider Communication Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT03824093?

This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03824093 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Communication

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.